Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2019, Vol. 39 Issue (5): 114-119    DOI: 10.13523/j.cb.20190513
综述     
免疫佐剂分类及作用机制
杨琳,傅哲彦,吕正兵,舒建洪()
浙江理工大学生命科学学院 杭州 310018
Classification and Mechanism of Immune Adjuvant
Lin YANG,Zhe-yan FU,Zheng-bing LV,Jian-hong SHU()
Zhejiang Sci-Tech University College of Life Sciencies and Medicine, Hangzhou 310018,China
 全文: PDF(426 KB)   HTML
摘要:

通过现代生物技术制成的DNA疫苗、重组疫苗和亚单位疫苗等新型疫苗,虽然安全性较传统疫苗有所提高,但其免疫原性不及传统疫苗,需要通过佐剂增强疫苗的免疫效力。随着对佐剂研究的不断深入,铝佐剂、油乳佐剂、微生物类佐剂、蜂胶佐剂、左旋咪唑佐剂、脂质体佐剂、中药佐剂及小肽类佐剂等相继问世,其作用机制也随研究的不断深入逐渐清晰。通过动物免疫实验结果发现,小肽类免疫佐剂不仅可以增强特异性免疫反应,具备免疫增强剂的功效,而且获取简单,便于运输保存,安全性高,可能是未来佐剂研究的一个主要方向。

关键词: 疫苗免疫佐剂作用机制    
Abstract:

Although new vaccines such as DNA vaccines, recombinant vaccines, and subunit vaccines obtained through modern biotechnology have been improved in safety compared to conventional vaccines, they also have certain defects. One of the biggest defects is that the immunogenicity is often low, and the efficacy of the immune body cannot be achieved. It is necessary to add an adjuvant or a carrier to improve the immune efficacy. Therefore, it is very important to develop an effective, safe and effective adjuvant to enhance the specific immune response. With the continuous development of adjuvants, aluminum adjuvant, oil emulsion adjuvant, microbial adjuvant, propolis adjuvant, levamisole adjuvant, liposome adjuvant, traditional Chinese medicine adjuvant and peptide adjuvant have been used as immunoadjuvants and its mechanism of action has also been studied more and more thoroughly. Through animal immunization experiments, it was found that peptide immunoadjuvant not only enhances specific immune response, but also has the effect of immune enhancer, and is easy to obtain, easy to transport and preserve, and has high safety, which may be a major direction of future adjuvant research.

Key words: Vaccine    Immune adjuvant    Mechanism of action
收稿日期: 2018-09-30 出版日期: 2019-06-04
ZTFLH:  Q819  
通讯作者: 舒建洪     E-mail: shujianhong@zstu.edu.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
杨琳
傅哲彦
吕正兵
舒建洪

引用本文:

杨琳,傅哲彦,吕正兵,舒建洪. 免疫佐剂分类及作用机制[J]. 中国生物工程杂志, 2019, 39(5): 114-119.

Lin YANG,Zhe-yan FU,Zheng-bing LV,Jian-hong SHU. Classification and Mechanism of Immune Adjuvant. China Biotechnology, 2019, 39(5): 114-119.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190513        https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I5/114

[1] Dowling J K, Mansell A . Toll-likereceptors:the swiss army knifeof immunity and vaccine development. ClinTransl Immunology, 2016,5(5):85-86.
[2] 臧力铭, 胡松华 . 疫苗免疫佐剂及其研究进展. 黑龙江畜牧兽医, 2004,46(3):61-62.
Yan L M, Hu S H . Vaccine immune adjuvant and its research progress. Heilongjiang Animal Husbandry and Veterinary, 2004,46(3):61-62.
[ ] SHAKYA A K, CHOWDHURY M Y, TAO W , et al. Mucosal vaccine delivery:current state and a pediatric perspective. J Control Release, 2016,240(10):394-413.
doi: 10.1016/j.jconrel.2016.02.014
[3] Bergmann-Leitner E S, Leitner W W . Adjuvants in the driver’s seat:how magnitude,type,fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators. Vaccines(Basel), 2014,2(2):252-296.
[4] Schulze K, Ebensen T, Babiuk L A , et al. Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticlebased vaccine formulation stimulates protective immune responses in mice. Nanomedicine, 2017,13(7):2169-2178.
doi: 10.1016/j.nano.2017.05.012
[5] 吴宣, 杨泽林, 岳华 , 等. 免疫佐剂的研究进展. 养禽与禽病防治, 2003,21(9):2-4.
Wu X, Yang Z L, Yue H , et al. Research progress of immunological adjuvants. Prevention and Control of Poultry and Poultry Diseases, 2003,21(9):2-4.
[6] Heydenreich B, Bellinghausen I, Lund L , et al. Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids-differences in vivo and in vitro. Clin Exp Immunol, 2014,176(3):310-319.
doi: 10.1111/cei.12294
[7] Miki H, Nakahashi-Oda C, Sumida T , et al. Involvement of CD300a phosphatidylserine immunoreceptor in aluminum salt adjuvantInduced Th2 responses. J Immunol, 2015,194(11):5069-5076.
doi: 10.4049/jimmunol.1402915
[8] Aikawa K, Matsumoto K, Uds H , et al. Prolonged release of drug from O/W emulsion and residence in rat nasal cavity. Pharm Dev Technol, 1998,3(4):461-469.
doi: 10.3109/10837459809028627
[9] Eisenbarth S C, Colegio O R, O’Connor W , et al. Calcial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminum adjuvant. Nature, 2008,453(7198):1122-1126.
[10] Ljutic B, Ochs M, Messham B , et al. Formulation, stability and immunogenicity of a trivalent pneumococcal proteinvaccine formulated with aluminumsalt adjuvants. Vaccine, 2012,30(19):2981-2988.
doi: 10.1016/j.vaccine.2012.02.038
[11] Li H, Willingham S B, Ting J P , et al. Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol, 2008,181(1):17-21.
doi: 10.4049/jimmunol.181.1.17
[12] Qing H, Alaina M, Tulin M , et al. Calcium phos phate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clin Diag Lab Immun, 2002,9(5):1021-1024.
[13] Baker J A, Lewis E L, Byland L M , et al. Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization. Vaccine, 2017,35(9):1273-1280.
doi: 10.1016/j.vaccine.2017.01.029
[14] 何海蓉, 姜平, 梅忠 . 不同来源白油佐剂质量分析及其制备的禽流感疫苗安全性与免疫效力研究. 中国家禽, 2009,31(22):15-18.
He H R, Jiang P, Mei Z . Quality analysis of different sources of white oil adjuvant and its safety and immune efficacy of avian influenza vaccine prepared. China Avian, 2009,31(22):15-18.
[15] Liu K F, Liu X R, Li G L , et al. Oral administration of Lactococcus lactis——expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice. Immunol Lett, 2016,174(1):28-36.
doi: 10.1016/j.imlet.2016.04.008
[16] Zhang X, Hu S, Du X , et al. Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development.[J] Microbiol Immunol Infect. 2016,49(6):851-858.
doi: 10.1016/j.jmii.2014.11.009
[17] Lofano G, Mancini F , SalvatoRE G,et al.Oilin-emulsion MF59 increases germinal center B cell differentiation and persistence in response to vaccination. J Immunol, 2015,195(4):1617-1627.
doi: 10.4049/jimmunol.1402604
[18] Xue X, Ding F, Zhang Q , et al. Stability and potency of the Plasmodium falciparum MSP119/AMA1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant. Vaccine, 2010,28(18):3152-3158.
doi: 10.1016/j.vaccine.2010.02.054
[19] MOSCHOS S A, BRAMWELL V W, SOMAVA RAPU S , et al. Comparative immunomodulatory properties of a chitosanMDP adjuvant combination following intranasal or intramuscular immunization[J]. Vaccine, 2005,23(16):1923-1930.
doi: 10.1016/j.vaccine.2004.10.016
[20] Ly N P, Litonjua A, Gold D R , et al. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy,asthma,and obesity. J Allergy Clin Immunol, 2011,127(5):1087-1094.
doi: 10.1016/j.jaci.2011.02.015
[21] Agmon Levin N, Theodor E, Segal R M , et al. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol, 2013,45(2):256-266.
doi: 10.1007/s12016-012-8342-y
[22] Wegienka G, Havestad S, Zoratti E M , et al. Association between vitamin D levels and allergy-related outcomes vary by race and other factors. J Allergy Clin Immunol, 2015,136(5):1309-1314.
doi: 10.1016/j.jaci.2015.04.017
[23] 王雪鹏, 刘悦竹, 陈蕾 , 等. 鸡痘蜂胶佐剂灭活疫苗的研制. 中国兽医杂志, 2005,41(4):52-53.
Wang X P, Liu Y Z, Chen L , et al. Development of inactivated vaccine for chicken pox propolis adjuvant. Chinese Journal of Veterinary Medicine, 2005,41(4):52-53.
[24] Sforcin J M . Propolis and the immune syetem. J Ethnopharm Acol, 2007,113(1):1-14.
doi: 10.1016/j.jep.2007.05.012
[25] Moschos S A, Bramwell V W, Somavarapu S , et al. Comparative immunomodulatory properties of a chitosan MDP adjuvant combination following intranasal or intramuscular immunization. Vaccine, 2005,23(16):1923-1930.
doi: 10.1016/j.vaccine.2004.10.016
[26] Allison A C . Liposomes as immunological adjuvants. Nature, 1974,105(2):252254.
[27] 何敏, 符华林, 李英伦 . 兽用脂质体制剂的研究进展. 中国兽药杂志, 2004,38(9):3337.
He M, Fu H L, Li Y L . Research progress in veterinary liposomal preparations. Chinese Journal of Veterinary Drug, 2004,38(9):3337.
[28] Brewer J M, Tetley L, Richmond J , et al. Lipod vesicle size determines the Th1 or Th2 response to entrappen antigen. Immunol, 1998,161(8):4000-4007.
[29] Highton A J, Kojarunchitt T, Girardin A , et al. Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma. Immunol Cell Biol, 2015,93(7):634-640.
doi: 10.1038/icb.2015.14
[30] Li Y, Xie F, Chen J , et al. Increased humoral immune responses of pigs to foot-and-mouth disease vaccine supplemented with ginseng stem and leaf saponins. Chem Biodivers, 2012,9(10):2225-2235.
doi: 10.1002/cbdv.v9.10
[31] Wang M, Yang R, Zhang L , et al. Sulfated glucan can improve the immune efficacy of Newcastle disease vaccine in chicken. Int J Biol Macromol, 2014,70(9):193-198.
doi: 10.1016/j.ijbiomac.2014.05.048
[32] Guo L, Liu J, Hu Y , et al. Astragalus polysaccharide and sulfated epimedium polysaccharide synergistically resist the immunosuppression. Carbohydr Polym, 2012,90(2):1055-1060.
doi: 10.1016/j.carbpol.2012.06.042
[33] 马兴铭, 赵进昌 . 中药多糖对小鼠巨噬细胞功能影响的比较. 甘肃中医学院学报, 2000,17(4):11-12.
Ma X M, Zhao J C . Comparison of effects of traditional Chinese medicine polysaccharide on mouse macrophage function. Journal of Gansu College of Traditional Chinese Medicine, 2000,17(4):11-12.
[34] 魏恒, 李娟娟 . 中药免疫增强剂在养鸡生产中的应用研究进展. 山西农业科学, 2018,46(11):1971-1974.
Wei H, Li J J . Advances in the application of traditional Chinese medicine immunopotentiators in chicken production. Shanxi Agricultural Science, 2018,46(11):1971-1974.
[35] Gordon D, Kelley P, Heinzel S , et al . Immunogenicity and safety of AdvaxTM, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen:A randomized controlled Phase 1 study. Vaccine, 2014,32(48):6469-6477.
doi: 10.1016/j.vaccine.2014.09.034
[36] Liu M, Machova E, Nescakova Z , et al. Vaccination with mannan protects mice against systemic aspergillosis. Med Mycol, 2012,50(8):818-828.
doi: 10.3109/13693786.2012.683539
[37] Gupta RK, Chang A C, Griffin P , et al. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeles tetanus toxoid. Vaccine, 1996,14(15):1412-1416.
doi: 10.1016/S0264-410X(96)00073-4
[38] Gao S, Li D, Liu Y , et al. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice. Int Immunopharmacol, 2015,24(1):140-145.
doi: 10.1016/j.intimp.2014.10.032
[39] Mosca F, Tritto E, Muzzi A , et al. Molecular and celluar signatures of human vaccine adjuvants. Proc Natl Acad Sci USA, 2008,105(30):10501-10506.
doi: 10.1073/pnas.0804699105
[40] Goto N, Akama K . Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid. Microbiol Immunol, 1982,26(12):1121-1132.
doi: 10.1111/mim.1982.26.issue-12
[41] Caproni E, Tritto E, Cortese M , et al. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action. Immunol, 2012,188(7):3088-3098.
doi: 10.4049/jimmunol.1101764
[42] 刘轶博, 耿兴超, 汪巨峰 , 等. 免疫佐剂作用机制研究新进展. 中国新药杂志, 2015,24(20):2324-2329.
Liu Y B, Gan X C, Wang J F , et al. Recent advances in the mechanism of immunoadjuvants. Chinese Journal of New Drugs, 2015,24(20):2324-2329.
[43] Seuber T A, Monaci E, Pizza M , et al. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. Immunol, 2008,180(8):5402-5412.
doi: 10.4049/jimmunol.180.8.5402
[44] 周洋, 耿兴超, 汪巨峰 , 等. 疫苗佐剂最新进展. 中国新药杂志, 2013,22(1):34-42.
Zhou Y, Yan X C, Wang J F , et al. Recent advances in vaccine adjuvants. Chinese Journal of New Drugs, 2013,22(1):34-42.
[45] Li H, Nookala S, Re F . Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. Immunol, 2007,178(8):5271-5276.
doi: 10.4049/jimmunol.178.8.5271
[46] 侯立婷, 陈瑾, 乔绪稳 , 等. 猪O型口蹄疫病毒细菌样颗粒疫苗的制备与免疫原性鉴定. 生物工程学报, 2017,33(2):217-227.
Hou L T, Chen J, Qiao X W , et al. Design and immunogenicity evaluation for the bacteria-like particle vaccine against swine type O foot-and-mouth disease virus. Chin J Biotech, 2017,33(2):217-227.
[47] Qin T, Chen J, Wang D , et al. Optimization of selenylation conditions for Chinese angelica polysaccharide based on immune-enhancing activity. Carbohydr Polym, 2013,92(1):645-650.
doi: 10.1016/j.carbpol.2012.08.097
[1] 朱嘉豪,陈婷,习欠云. miR-146a参与不同疾病的研究进展*[J]. 中国生物工程杂志, 2021, 41(9): 64-70.
[2] 肖云喜,张俊河,杨雯雯,程洪伟. 用于疫苗生产的人二倍体细胞研究进展*[J]. 中国生物工程杂志, 2021, 41(11): 74-81.
[3] 朱潇静,王芮,张欣欣,靳家鑫,路闻龙,丁大顺,霍翠梅,李青梅,孙爱军,庄国庆. 利用细菌人工染色体技术构建整合F基因的重组MDV疫苗株*[J]. 中国生物工程杂志, 2021, 41(10): 33-41.
[4] 程旭,杨雨睛,吴赛男,侯勤龙,李咏梅,韩慧明. 金黄色葡萄球菌SarAIcaA及其融合基因的DNA疫苗构建及在小鼠免疫应答中的初步研究 *[J]. 中国生物工程杂志, 2020, 40(7): 41-50.
[5] 刘珍珍,田大勇. 狂犬病疫苗蔗糖密度梯度离心纯化工艺开发 *[J]. 中国生物工程杂志, 2020, 40(4): 25-33.
[6] 钱颖,钱晨,白晓庆,王晶晶. 免疫佐剂在肿瘤免疫疗法中的应用进展 *[J]. 中国生物工程杂志, 2020, 40(3): 96-103.
[7] 谢华玲,吕璐成,杨艳萍. 全球冠状病毒疫苗专利分析[J]. 中国生物工程杂志, 2020, 40(1-2): 57-64.
[8] 井汇源,段二珍,董望. 体外转录的自我复制型mRNA疫苗研究进展*[J]. 中国生物工程杂志, 2020, 40(12): 25-30.
[9] 廖小艳,陈丽丽. COVID-19疫苗研究现状*[J]. 中国生物工程杂志, 2020, 40(12): 8-17.
[10] 冯雪娇,侯海龙,喻琼,王俊姝. 我国宫颈癌疫苗市场分析及对策研究*[J]. 中国生物工程杂志, 2020, 40(11): 96-101.
[11] 高彦,杜晶晶,王斌,刘琦,申志强. 气相色谱法对狂犬病疫苗灭活工艺中β-丙内酯研究[J]. 中国生物工程杂志, 2019, 39(6): 25-31.
[12] 许嘉越,李紫倩,张革. 登革病毒3'UTRΔ30系列疫苗的研究进展[J]. 中国生物工程杂志, 2019, 39(3): 97-104.
[13] 蒋析文,董子维,刘悦,朱小亚. 生物标记物与精准医疗研究进展[J]. 中国生物工程杂志, 2019, 39(2): 74-81.
[14] 孙思,邱喻兰,颜菊荣,杨静,吴光英,王玲,胥文春. 重组质粒pcDNA3-dnaJ/蛋白DnaJ异源免疫诱导Th1和Th17细胞免疫应答抵抗肺炎链球菌感染 *[J]. 中国生物工程杂志, 2019, 39(12): 9-17.
[15] 郭乐,王淑娥,何萌,张帆,刘宏鹏,刘昆梅. 幽门螺杆菌多价表位疫苗CWAE的表达及其免疫学性质的研究 *[J]. 中国生物工程杂志, 2019, 39(12): 1-8.